Related Experiment Video
Updated: Sep 7, 2025

Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models
Published on: June 20, 2025
Progressive massive fibrosis: An overview of the recent literature
1National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV, United States of America.
Abstract:
This review provides an overview of literature addressing progressive massive fibrosis (PMF) from September 2009 to the present. Advances are described in understanding its pathophysiology, epidemiology of the occurrence of PMF and related conditions, the impact of PMF on pulmonary function, advances in imaging of PMF, and factors affecting progression of pneumoconiosis in dust-exposed workers to PMF. Basic advances in understanding the etiology of PMF are impeded by the lack of a well-accepted animal model for human PMF. Recent studies evaluating lung tissue samples and epidemiologic investigations support an important role for the silica component of coal mine dust in causing coal workers' pneumoconiosis and PMF in contemporary coal miners in the United States and for silica in causing silicosis and PMF in artificial stone workers throughout the world. Development of PMF is associated with substantial decline in pulmonary function relative to no disease or small opacity pneumoconiosis. In recent reports, computed tomography has had greater sensitivity for detecting PMF than chest x-ray. Magnetic resonance imaging shows promise in differentiating between PMF and lung cancer. Although PMF develops in dust-exposed workers without previously identified small opacity pneumoconiosis, the presence of small opacity pneumoconiosis increases the risk for progression to PMF, as does heavier dust exposure. Recent literature does not document any effective new treatments for PMF and new therapies to prevent and treat PMF are an important need.
Insights
Progressive massive fibrosis (PMF) is linked to silica exposure in coal miners and artificial stone workers. Current treatments are lacking, highlighting an urgent need for new therapies to prevent and manage this severe lung disease.
Area of Science:
- Occupational Medicine
- Pulmonary Medicine
- Toxicology
Background:
- Progressive massive fibrosis (PMF) is a severe lung disease linked to dust exposure.
- Understanding PMF's pathophysiology and epidemiology is crucial for developing effective interventions.
- Current literature lacks comprehensive reviews on recent PMF advancements.
Purpose of the Study:
- To review recent literature on progressive massive fibrosis (PMF) from 2009 to present.
- To summarize advances in PMF pathophysiology, epidemiology, and clinical impact.
- To identify gaps in knowledge and unmet needs in PMF prevention and treatment.
Main Methods:
- Comprehensive literature review of studies published from September 2009 to the present.
- Analysis of research on PMF etiology, progression, and diagnostic imaging.
- Evaluation of epidemiological data on dust-exposed workers and PMF development.
Main Results:
- Silica in coal mine dust and artificial stone dust is strongly implicated in causing PMF.
- PMF significantly impairs pulmonary function compared to less severe pneumoconiosis.
- Computed tomography (CT) shows higher sensitivity for PMF detection than chest X-ray; MRI shows potential for differentiating PMF from lung cancer.
Conclusions:
- PMF development is associated with silica exposure and increased dust exposure.
- While PMF can occur without prior small opacity pneumoconiosis, its presence increases risk.
- There is a critical need for novel therapies to prevent and treat progressive massive fibrosis.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Introduction to Fibroblasts
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

